维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="LIPSKAIA L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Molecular targets in heart failure gene therapy: current controversies and transla- tional perspectives显示文摘	Kairouz V Lipskaia L Hajjar R J	2012	Ann N Y Acad Sci2012，1254，：	1
2	Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure 显示文摘	Lipskaia L Chernaly ER Hadri L	2010	Expert Opin Biol Ther2010，10，1：	1
3	Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation显示文摘	Lompre' AM	2004	Biol Cell2004，96，：	1
4	Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation显示文摘	Pourci ML Delomenie C	2003	Circ Res2003，92，：	1
5	Molecular targets in heart failure gene therapy: current controversies and translational perspec- tives显示文摘	Kairouz V Lipskaia L Hajjar RJ	2012	Ann N Y Acad Sci2012，1254，：	1
6	A calcium-sensitive pro- moter construct for gene therapy 显示文摘	Merlet E Lipskaia L Marchand A	2013	C ene Ther2013，20，3：	1
7	Sarcoplasmicreticulum Ca2+ ATPase as a therapeutic target for heartfailure显示文摘	Lipskaia L Chemaly ER Hadri L	2010	Expert Opin Biol Ther2010，10，1：	1
8	Expression of sarco(endo) plasmic reticulum calcium ATPase(SERCA) system in normal mouse cardiovascular tis- sues, heart failure and atberosclerosis显示文摘	Lipskaia L Keuylian Z Blirando K	2014	Biochim Biophys Acta2014，1843，11：	1
9	Multidrug resistance associated protein 4 regulates AMP-dependent signaling pathways and controls human and rat SMC proliferation显示文摘	Sassi Y Lipskaia L Vandecasteele G		0，，08：	1
10	Sarcoplasmic reticulumCa2+ ATPase as a therapeutic target for heart failure显示文摘	Lipskaia L Chemaly ER Hadri L	2010	ExpertOpin Biol Ther2010，10，1：	1
11	Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation 显示文摘	Lipskaia L Hulot JS Lompre AM	2009	Pflugers Arch2009，457，3：	1
12	Phosphoinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation显示文摘	Lipskaia L Pourci M-L Delomenie C	2003	Circ Res2003，92，10：	1
13	Sarcoplasmic reticulum Ca2+ ATPase as a therapeutic for heart failure显示文摘	LIPSKAIA L CHEM ALY ER HADRI L	2010	Expert Opin Biol Ther2010，10，1：	1
14	Role of sarco/ endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation 显示文摘	Lipskaia L Hulot J S Lompre A M	2009	Pflugers Arch2009，457，3：	1
15	Synergistic role of protein phosphatase inhibitor I and sarco/endoplasmic reticulum Ca2 +-ATPase in the acquisition of the contractile phenotype of arterial smooth muscle cells显示文摘	Lipskaia L Bobe R Chen J	2014	Circulation2014，129，7：	1
16	Adenylyl cyclase activity and gene expression during mesodermal differentiation of the P19 embryonal carcinoma cells显示文摘	Lipskaia L Grepin C Defer N	1998	J Cell Physiol1998，176，1：	1
17	Phosphatidylinositol 3 - kinase and calcium- activated transcription pathways are required for VLDL- induced smooth muscle cell proliferation 显示文摘	Lipskaia L Pourci ML Delomenie C	2003	Circ Res2003，92，：	1
18	Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation显示文摘	Lipskaia L Pourci ML Delomenie C	2003	Circ Res2003，92，10：	1
19	Muhidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation 显示文摘	Sassi Y Lipskaia L Vandecasteele G	2008	J Clin Invest2008，118，8：	1
20	Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure显示文摘	Lipskaia L Chemaly ER Hadri L	2010	Expert Opin Biol Ther2010，10，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示